Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-malignant Disease”

1,089 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,089 results

Early research (Phase 1)Study completedNCT06469138
What this trial is testing

Investigate 14C-bemcentinib in Healthy Male Subjects

Who this might be right for
Non-Small Cell Lung CancerMetastatic MelanomaAcute Myeloid Leukemia+5 more
BerGenBio ASA 6
Testing effectiveness (Phase 2)Study completedNCT00007982
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer

Who this might be right for
Brain and Central Nervous System TumorsHead and Neck CancerLymphoma
Herbert Irving Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT01010126
What this trial is testing

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaEndometrial Serous Adenocarcinoma+42 more
National Cancer Institute (NCI) 252
Testing effectiveness (Phase 2)Study completedNCT00448201
What this trial is testing

Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
UNC Lineberger Comprehensive Cancer Center 71
Early research (Phase 1)Looking for participantsNCT06043466
What this trial is testing

A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors

Who this might be right for
Colorectal CancerEsophagus CancerGastric Cancer+4 more
Chongqing Precision Biotech Co., Ltd 30
Testing effectiveness (Phase 2)Study completedNCT03740529
What this trial is testing

Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL

Who this might be right for
Chronic Lymphocytic LeukemiaWaldenstrom MacroglobulinemiaMantle Cell Lymphoma+3 more
Loxo Oncology, Inc. 803
Early research (Phase 1)Study completedNCT00879866
What this trial is testing

EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung CancerNon Small Cell Lung Cancer
Merck KGaA, Darmstadt, Germany 15
Not applicableStudy completedNCT01963351
What this trial is testing

Bevacizumab in Combination With Chemotherapy in Patients With Advanced or Recurrent Non-squamous NSCLC

Who this might be right for
Non-small Cell Lung CancerUnresectable Malignant Neoplasm
University of Athens 150
Testing effectiveness (Phase 2)Study completedNCT02277639
What this trial is testing

Reduced Intensity Conditioning Using CD3+/CD19+ Depletion for Non Malignant Transplantable Diseases

Who this might be right for
Bone Marrow Failure SyndromesImmunodeficienciesImmune Dysregulation Syndromes
Children's Hospital of Philadelphia 2
Testing effectiveness (Phase 2)Study completedNCT00231465
What this trial is testing

Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 44
Testing effectiveness (Phase 2)WithdrawnNCT01415765
What this trial is testing

MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma

Who this might be right for
Lymphoma, Diffuse Large-Cell B-cellDiffuse, Large B-cell LymphomaLymphoma, Diffuse Large-Cell+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00309842
What this trial is testing

Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+10 more
Masonic Cancer Center, University of Minnesota 213
Testing effectiveness (Phase 2)Looking for participantsNCT07252739
What this trial is testing

KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)

Who this might be right for
Malignant Neoplasm
Merck Sharp & Dohme LLC 130
Early research (Phase 1)Ended earlyNCT00585845
What this trial is testing

Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment

Who this might be right for
Malignant Epithelial MesotheliomaAdenocarcinoma of the PancreasCarcinoma, Non-Small-Cell Lung+1 more
Anza Therapeutics, Inc. 17
Early research (Phase 1)Study completedNCT00003962
What this trial is testing

Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Active Not RecruitingNCT04491942
What this trial is testing

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

Who this might be right for
Advanced Bile Duct CarcinomaAdvanced Breast CarcinomaAdvanced Cervical Carcinoma+31 more
National Cancer Institute (NCI) 74
Testing effectiveness (Phase 2)Study completedNCT03213678
What this trial is testing

Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin Lymphoma+30 more
National Cancer Institute (NCI) 18
Large-scale testing (Phase 3)Ended earlyNCT00384891
What this trial is testing

Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer

Who this might be right for
Urinary Bladder DiseasesUrinary Bladder NeoplasmsUrinary Bladder Cancer+5 more
Medical Enterprises Europe B.V. 190
Early research (Phase 1)Active Not RecruitingNCT04483778
What this trial is testing

B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

Who this might be right for
Pediatric Solid TumorGerm Cell TumorRetinoblastoma+14 more
Seattle Children's Hospital 68
Not applicableStudy completedNCT02679378
What this trial is testing

Exploratory Study Comparing ClearSight System 2D Map to Post Surgery Histopathological Analysis in Lumpectomy

Who this might be right for
Breast Cancer
Clear Cut Medical Ltd. 220
Load More Results